NIR-II fluorescence in lung cancer: advancing precision diagnosis and image-guided therapy
Frontiers in Chemistry · 14.01.2026 · 13
DOI: 10.3389/fchem.2025.1720197 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Chemistry, online erschienen am 14.01.2026. Verfasst von YunLong Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Suining Central Hospital, Suining, Sichuan, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lung cancer ranks among the leading causes of cancer incidence and mortality worldwide. Conventional diagnostic and therapeutic approaches remain constrained by suboptimal sensitivity, exposure to ionizing radiation, and poor overall prognosis, driving efforts to develop novel diagnostic and therapeutic strategies to improve clinical outcomes. Second near-infrared window (NIR-II) fluorescence imaging offers deep tissue penetration and high spatial resolution; accordingly, a wide array of NIR-II fluorescent probes, imaging systems, and photointerventional therapies have been developed. In this review, we summarize recent advances and applications of NIR-II in lung cancer diagnosis and treatment and discuss the design and future directions of integrated diagnostic-therapeutic (theranostic) platforms.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Suining Central Hospital, Suining, Sichuan, China.
- Medical Imaging Key Laboratory of Sichuan Province, North Sichuan Medical College, Nanchong, Sichuan, China.
- Institute of Surgery, Graduate School, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Institute of Surgery, Graduate School, North Sichuan Medical College, Nanchong, China.
- Department of Thoracic Surgery, Affiliated Hospital of Southwest Medical University, Luzhou, China.
- College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Zitieren
APA
Yang, Y., Fu, J., Xie, R., Wang, C., Wang, S., Wen, L., Yang, Y., Liu, C., Yi, G., Yu, L., & Zhou, H. (2026). NIR-II fluorescence in lung cancer: advancing precision diagnosis and image-guided therapy. Frontiers in Chemistry, 13. https://doi.org/10.3389/fchem.2025.1720197
Vancouver
Yang Y, Fu J, Xie R, Wang C, Wang S, Wen L, et al. NIR-II fluorescence in lung cancer: advancing precision diagnosis and image-guided therapy. Frontiers in Chemistry. 2026;13. doi:10.3389/fchem.2025.1720197
BibTeX
@article{Yang2026,
author = {Yang, YunLong and Fu, Jiang and Xie, RangPing and Wang, Chun and Wang, Sen and Wen, Long and Yang, Yang and Liu, ChengKuan and Yi, GuiYan and Yu, Li and Zhou, HaiNing},
title = {NIR-II fluorescence in lung cancer: advancing precision diagnosis and image-guided therapy},
journal = {Frontiers in Chemistry},
year = {2026},
volume = {13},
doi = {10.3389/fchem.2025.1720197}
}
EUVIMED